Drug industry vendor Kalderos last week launched a new drug discount platform with 340B rebate capabilities as its prior lawsuit [...] …
Category: Providers
Breaking News
J&J Abandons 340B Rebate Due to HRSA’s Enforcement Threats But Defends Model in Letter to Agency
Johnson & Johnson (J&J) notified the Health Resources and Services Department (HRSA) this morning that it will drop its 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Sanofi is requiring Arkansas hospitals to prove they legally own 340B-priced drugs until they are dispensed at contract pharmacies after [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal regulators last Friday finalized a highly anticipated rule for the Medicaid Drug Rebate Program (MDRP) with new identifiers and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major hospital group recently hit back against the drug industry’s claims that hospital behavior has helped drive “out of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
An influential Republican senator this morning requested detailed information from Eli Lilly and Amgen on their 340B programs, including the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal government’s recent threat to penalize Johnson & Johnson (J&J) for its unapproved 340B rebate model could spark a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The sponsor of new Senate legislation that would codify providers’ ability to use contract pharmacies to dispense 340B discounted drugs [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Washington, D.C.-based children’s hospital has sued the federal government for authorizing drugmaker Johnson & Johnson (J&J) to perform “unlawful” [...] …
